About: Prabodh kumar Kandala
- Website
- http://prabodhkandala.wordpress.com
- Details
- I am a pharmaceutical research scientist. I like to talk to people, listen to their problems and help them if needed. I like to motivate people. I sing, dance, write poems etc. I love to blog as well.
Posts by Prabodh kumar Kandala:
-
February 4, 2013 Hold on. Mutations in Cancer do good.
-
December 8, 2012 Dasatinib in Combination With Other Drugs for Advanced, Recurrent Ovarian Cancer
-
December 8, 2012 Squeezing Ovarian Cancer Cells to Predict Metastatic Potential: Cell Stiffness as Possible Biomarker
-
November 11, 2012 Metabolic drivers in aggressive brain tumors
-
October 23, 2012 Breakthrough Technique Images Breast Tumors in 3-D With Great Clarity, Reduced Radiation
-
September 23, 2012 Warning signs may lead to better early detection of ovarian cancer
-
September 19, 2012 Arsenic levels in rice and rice products
-
September 18, 2012 Imaging agent to detect Prostate cancer-now a reality
-
September 1, 2012 Asthma Drug Prevents Spread of Breast Cancer, Study Finds
-
September 1, 2012 Marijuana Compound Shows Promise In Fighting Breast Cancer
Follow Blog via Email
Join 2,041 other subscribers-
Recent Posts
- FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
- Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
- In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
- Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
- AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
- In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
- Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
- 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
- Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI-in-Health, Life Sciences & BioPharma June 15, 2026
- Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
Archives
Categories
Meta